EQUALINE extra strength
Presence of foreign substance: small metallic particles in chewable tablets.
2,357 recalls · Class II, newest first
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Presence of foreign substance: small metallic particles in chewable tablets.
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona